Although pMMR CRC is recognized as a “cold tumor”, - tumor-infiltrating lymphocytes (TILs), particularly CD8+ cytotoxic T cells, are also observed and associated with better prognosis and response to immune checkpoint inhibition therapy [8, 9]. This evidence concerns the gene CD8A and colorectal carcinoma.